Concepedia

David Hendlin

DH

46

Publications

2.6K

Citations

24

H-Index

1949

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Cepsa (Spain)

David Hendlin is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in microbiology, medicine, and biochemistry.

Top concepts

Publications per year

1949–1980

46

Publications

46

Phosphonomycin, a New Antibiotic Produced by Strains of <i>Streptomyces</i>

David Hendlin, E. O. Stapley, M. Jackson et al. · Science · 1969 · 577 citations

, , +13

Thienamycin, a new .BETA.-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties.

Jean S. Kahan, Frederick M. Kahan, Robert T. Goegelman et al. · The Journal of Antibiotics · 1979 · 505 citations · Full text

Cephamycins, a New Family of β-Lactam Antibiotics I. Production by Actinomycetes, Including <i>Streptomyces lactamdurans</i> sp. n

E. O. Stapley, M. Jackson, Sebastian Hernandez et al. · Antimicrobial Agents and Chemotherapy · 1972 · 177 citations · Full text

Cefoxitin, a Semisynthetic Cephamycin Antibiotic: Resistance to Beta-Lactamase Inactivation

Hiroshi Ōnishi, Donald R. Daoust, S. B. Zimmerman et al. · Antimicrobial Agents and Chemotherapy · 1974 · 154 citations · Full text

Cefoxitin, a Semisynthetic Cephamycin Antibiotic: Susceptibility Studies

H. Wallick, David Hendlin · Antimicrobial Agents and Chemotherapy · 1974 · 106 citations · Full text

Rows per page

1–5 of 46